Document is current
Any future updates will be listed below
-
Authors
Jaeger, Benedikt
Schupp, Jonas Christian https://orcid.org/0000-0002-7714-8076
Plappert, Linda https://orcid.org/0000-0002-4642-383X
Terwolbeck, Oliver https://orcid.org/0000-0003-4312-0005
Artysh, Nataliia https://orcid.org/0000-0002-9807-1506
Kayser, Gian https://orcid.org/0000-0002-0587-9742
Engelhard, Peggy
Adams, Taylor Sterling https://orcid.org/0000-0003-4280-9070
Zweigerdt, Robert https://orcid.org/0000-0002-4656-0770
Kempf, Henning https://orcid.org/0000-0003-2790-9137
Lienenklaus, Stefan https://orcid.org/0000-0003-4790-3445
Garrels, Wiebke https://orcid.org/0000-0003-0737-1245
Nazarenko, Irina
Jonigk, Danny https://orcid.org/0000-0002-5251-2281
Wygrecka, Malgorzata https://orcid.org/0000-0002-3656-2932
Klatt, Denise https://orcid.org/0000-0002-0301-6206
Schambach, Axel https://orcid.org/0000-0003-2743-0070
Kaminski, Naftali https://orcid.org/0000-0001-5917-4601
Prasse, Antje https://orcid.org/0000-0002-7336-7458
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KFO311)
Fraunhofer-Gesellschaft (Attract)
Bundesministerium für Wissenschaft, Forschung und Wirtschaft (DZL-BREATH)
- License Information
-
More Information
Article History
Received: 6 October 2020
Accepted: 7 September 2022
First Online: 26 September 2022
Competing interests
: The authors declare the following competing interests: N.K. is or has been a consultant to Biogen Idec, Boehringer Ingelheim, Third Rock, Pliant, Samumed, NuMedii, Indalo, Theravance, LifeMax, Three Lake Partners, Optikira, and received non-financial support from Miragen and NuMedii. In addition, N.K. has patents on New Therapies in Pulmonary Fibrosis, Cell Targeting and Peripheral Blood Gene Expression N.K. and J.C.S. are inventors on a provisional patent application (62/849,644) submitted by NuMedii, Inc., Yale University and Brigham and Women’s Hospital, Inc. that covers methods related to IPF-associated cell subsets. A.P. is a consultant to Boehringer Ingelheim, Roche, Pliant, Indalo, Nitto Denko and Astra Zeneca. A.P. and J.C.S. have patents on New Therapies in Pulmonary Fibrosis. The following authors declare no competing interests: B.J., L.P., O.T., N.A., G.K., P.E., T.S.A., R.Z., H.K., S.L., W.G., I.N., D.J., M.W., D.K., and A.S.
